These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7785970)

  • 61. Comparative effect of the naphthalenic ansamycins rifamycin SV, rifampin and cyclopentylrifampicin on murine neutrophil function.
    Kenny MT; Torney HL; Balistreri FJ
    Int J Immunopharmacol; 1989; 11(8):915-20. PubMed ID: 2559042
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623.
    Alexander DC; Jones JR; Liu J
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3208-13. PubMed ID: 14506032
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biogenesis of rifamycins. The conversion of rifamycin B into rifamycin Y.
    Lancini GC; Thiemann JE; Sartori G; Sensi P
    Experientia; 1967 Nov; 23(11):899-900. PubMed ID: 6056996
    [No Abstract]   [Full Text] [Related]  

  • 64. Genetic antagonism and hypermutability in Mycobacterium smegmatis.
    Karunakaran P; Davies J
    J Bacteriol; 2000 Jun; 182(12):3331-5. PubMed ID: 10852861
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.
    Li AP; Reith MK; Rasmussen A; Gorski JC; Hall SD; Xu L; Kaminski DL; Cheng LK
    Chem Biol Interact; 1997 Nov; 107(1-2):17-30. PubMed ID: 9402947
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rifamycin Derivatives Are Effective Against Staphylococcal Biofilms In Vitro and Elutable From PMMA.
    Sanchez CJ; Shiels SM; Tennent DJ; Hardy SK; Murray CK; Wenke JC
    Clin Orthop Relat Res; 2015 Sep; 473(9):2874-84. PubMed ID: 25896136
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Study on the sequences of amino-acids and their gene codes of the related proteins of rifampin-dependent Mycobacterium tuberculosis].
    Zhong M; Wang YW; Hu PP; Bao JL; Zhong J; Hu ZY; Luo YA
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):83-6. PubMed ID: 16677447
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Investigation of drug-resistance to rifampin and rpoB gene sequence analysis of Mycobacterium abscessus].
    Sha W; Weng XH; Xiao HP; He GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Sep; 26(9):544-7. PubMed ID: 14521758
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.
    Furesz S; Scotti R; Pallanza R; Mapelli E
    Arzneimittelforschung; 1967 May; 17(5):534-7. PubMed ID: 5631581
    [No Abstract]   [Full Text] [Related]  

  • 70. Activity of rifampin against Mycobacterium tuberculosis in a reference center.
    Ruiz P; Gutierrez J; Rodríguez-Cano F; Zerolo FJ; Casal M
    Microb Drug Resist; 2004; 10(3):239-42. PubMed ID: 15383168
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro and in vivo activities of new rifamycin derivatives against mycobacterial infections.
    Lounis N; Roscigno G
    Curr Pharm Des; 2004; 10(26):3229-38. PubMed ID: 15544512
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
    Rastogi N; Labrousse V
    Antimicrob Agents Chemother; 1991 Mar; 35(3):462-70. PubMed ID: 1828135
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Application of PCR-SSCP technique in detection of rpoB gene mutation in rifampin-resistant Mycobacterium tuberculosis].
    He X; Zhuang Y; Li G
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Dec; 19(6):338-41. PubMed ID: 9596814
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel degradation of rifamycin: isolation of the new ansa chain derivative from rifampicin.
    Kinoshita M; Tatsuta K; Nakata M
    J Antibiot (Tokyo); 1978 Jun; 31(6):630-1. PubMed ID: 681247
    [No Abstract]   [Full Text] [Related]  

  • 75. In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species.
    Varaldo PE; Debbia E; Schito GC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):615-8. PubMed ID: 3847272
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Detection of rpoB gene mutations in Mycobacterium tuberculosis].
    Yin LF; Lu XD; Meng SJ; Wang R
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Apr; 39(2):185-9. PubMed ID: 16944591
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of phagocyte membrane stimulation on antibiotic uptake and intracellular bactericidal activity.
    Steinberg TH; Hand WL
    Antimicrob Agents Chemother; 1987 Apr; 31(4):660-2. PubMed ID: 3606071
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of rifampicin on Mycobacterium smegmatis.
    Majtán V; L' Drobnica ; Miko M
    Folia Microbiol (Praha); 1982; 27(2):81-6. PubMed ID: 6177616
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Corneal penetration of rifampin.
    Feldman MF; Moses RA
    Am J Ophthalmol; 1977 Jun; 83(6):862-5. PubMed ID: 326055
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Susceptibility test to rifampin by using quantitative analysis of Mycobacterium tuberculosis mRNA].
    Lu Y; Zhu LZ; Chu NH; Duan LS; Liang GF
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):549-52. PubMed ID: 15388006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.